CLOs on the Move

Novabay

www.novabay.com

 
We are passionate about improving people`s daily lives by offering clinically proven solutions to common skin and eye care problems through digital channels, traditional domestic retailers, and international distributors. We are in the process of growing from a small single-product company into a profitable mid-sized multi-product company. Our leading product, Avenova®, is the only lid & lash solution that brings eyes back to life by setting the highest standards of purity and efficacy. We pioneered the use of hypochlorous acid in the eyecare space and intend on making Avenova a household name. Our motto is, “If you have eyes, you ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.novabay.com
  • 2000 Powell Street Suite 1150
    Emeryville, CA USA 94608
  • Phone: 510.899.8800

Executives

Name Title Contact Details
Justin Hall
Interim President, Chief Executive Officer, General Counsel and Corporate Compliance Officer Profile

Similar Companies

Hysitron

Hysitron is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armstrong Pharmaceuticals Inc

Armstrong Pharmaceuticals, Inc. was founded in 1955 as a manufacturer of specialty aerosol products. Armstrong produced a wide array of topical, personal care, and pharmaceutical products. Since 1993, Armstrong has focused exclusively on pharmaceutical

Kaup Pharmacy

Kaup Pharmacy is a Fort Recovery, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trimeris

Trimeris is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cellectis

Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 20 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells.